Kristian Reich, Chief Scientific Officer at MoonLake Immunotherapeutics (MLTX), sold 52,448 shares at $20.02 ($1.0M) on 2026-07-21, disclosed to the SEC on 2026-07-23.
Scheduled sale ($1.0M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.02 | 50,000 | $1.0M | 95.3% |
| 2 | $20.00 | 2,448 | $49K | 4.7% |
| Total | $20.02 avg | 52,448 | $1.0M | 100% |
| Filing → |
| MLTX | SELL | 2026-07-20 | $322K | — | Filing → |
| MLTX | SELL | 2026-06-17 | $2.9M | — | Filing → |
| MLTX | SELL | 2025-12-10 | $4.1M | — | Filing → |